Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine Supplementation in Moderate to Severe Asthma
NCT00280683Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Dec 2004
- Primary completion
- Nov 2008
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine in asthma, sponsored by University of California, Davis. Started Dec 2004; status: completed.
02
Drugs
arginine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00280683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280683.